Gastrointestinal adverse events · people with depression after stroke
It is very uncertain whether pharmacological interventions changes adverse events: all ‐ gastrointestinal effects (e.g. constipation,… compared with placebo (very low certainty).
1 finding from 1 review
Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke
It is very uncertain whether non‐invasive brain stimulation changes depression: < 50% reduction in scale scores at end of treatment… compared with sham non‐invasive brain stimulation and/or usual care (very low certainty).
1 finding from 1 review
Intervention not reported
Mean BCVA (logMAR) · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention showed no clear difference in mean BCVA (logMAR) (low certainty).
1 finding from 1 review
Intervention not reported
Early POVCH Â · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention probably leads to lower early POVCH Â (moderate certainty).
1 finding from 1 review
Intervention not reported
Late POVCH Â · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention leads to lower late POVCH Â (high certainty).
1 finding from 1 review
Intervention not reported
Revision surgery for POVCH · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention showed no clear difference in revision surgery for POVCH (moderate certainty).
1 finding from 1 review
Intervention not reported
Revision surgery for recurrent traction and/or RRD · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention showed no clear difference in revision surgery for recurrent traction and/or RRD (low certainty).
1 finding from 1 review
Intervention not reported
Intraoperative retinal breaks · people with proliferative diabetic retinopathy undergoing vitrectomy
The intervention leads to lower intraoperative retinal breaks (high certainty).
1 finding from 1 review
Intervention not reported
Silicone oil use · people with proliferative diabetic retinopathy undergoing vitrectomy
It is very uncertain whether the intervention changes silicone oil use (very low certainty).
1 finding from 1 review
Global evaluation · otherwise healthy adults and children with common cold symptoms
Antihistamine‐decongestant probably leads to lower global evaluation compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects: all · otherwise healthy adults and children with common cold symptoms
Analgesic‐decongestant leads to higher adverse effects: all compared with placebo (high certainty).
1 finding from 1 review
Adverse effects: drowsiness, hypersomnia, lethargy, excessive sleepiness, and other central nervous system adverse effects · otherwise healthy adults and children with common cold symptoms
Analgesic‐decongestant showed no clear difference in adverse effects: drowsiness, hypersomnia, lethargy, excessive… compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects: dry mouth · otherwise healthy adults and children with common cold symptoms
Analgesic‐decongestant showed no clear difference in adverse effects: dry mouth compared with placebo (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · otherwise healthy adults and children with common cold symptoms
Analgesic‐decongestant showed no clear difference in adverse effects: gastrointestinal compared with placebo (high certainty).
1 finding from 1 review
Adverse effects: dizziness, lightheadedness · otherwise healthy adults and children with common cold symptoms
Analgesic‐decongestant leads to higher adverse effects: dizziness, lightheadedness compared with placebo (high certainty).
1 finding from 1 review
Global evaluation · otherwise healthy adults and children with common cold symptoms
Antihistamine‐analgesic‐decongestant showed no clear difference in global evaluation: after 3 days of treatment (included children 2 to… compared with placebo (low certainty).
2 findings from 1 review
Global evaluation: after 5 days of treatment (included children 2 to 12 years old only) · otherwise healthy adults and children with common cold symptoms
Antihistamine‐analgesic‐decongestant showed no clear difference in global evaluation: after 5 days of treatment (included children 2 to… compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: all · otherwise healthy adults and children with common cold symptoms
Antihistamine‐decongestant showed no clear difference in adverse effects: all compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects: drowsiness, hypersomnia, and excessive sleepiness · otherwise healthy adults and children with common cold symptoms
Antihistamine‐decongestant showed no clear difference in adverse effects: drowsiness, hypersomnia, and excessive sleepiness compared with placebo (low certainty).
1 finding from 1 review
Adverse effects: dry mouth · otherwise healthy adults and children with common cold symptoms
Antihistamine‐decongestant leads to higher adverse effects: dry mouth compared with placebo (high certainty).
1 finding from 1 review